List Drug Candidate

BioNeex Interviews

BioNeex Interviews are part of the BioNeex vision. They provide a social media exposure to early stage biotech companies and their R&D pipelines in order to attract the right licensing and co-development partners. During the interview the interviewee, typically a biotech CEO, addresses the company’s message to potential partners, investors and other external stakeholders.
CEO of Moexa Pharmaceuticals Anthony Desir

Moexa's novel patented therapeutics targets tumor related SMAD3 cells by way of the TGF-β pathway and was developed to focus

Nov 29, 2022

OX2 Therapeutics, Dr. Michael Olin

OX2 Therapeutics is a clinical-stage biopharmaceutical company developing new therapies to turn cancers into manageable and p

Jun 18, 2021